Atlas Trials

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Clinical trial NCT00363987 · COMPLETED

Trial details

NCT number
NCT00363987
Sponsor
Fresenius Kabi
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Nephropathy
Start date
2006-05-01
Primary completion
2008-12-01
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.